These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31900853)

  • 21. Initial heritable genome editing: mapping a responsible pathway from basic research to the clinic.
    Ranisch R; Trettenbach K; Arnason G
    Med Health Care Philos; 2023 Mar; 26(1):21-35. PubMed ID: 36414813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline Editing: Editors Cautionary.
    Krishan K; Kanchan T; Singh B; Baryah N; Puri S
    Clin Ter; 2018; 169(2):e58-e59. PubMed ID: 29595865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethical issues of CRISPR technology and gene editing through the lens of solidarity.
    Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R;
    Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethics of Human Genome Editing.
    Coller BS
    Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thinking About CRISPR: The Ethics of Human Genome Editing.
    Barrangou R
    CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
    [No Abstract]   [Full Text] [Related]  

  • 26. CRISPR/Cas9 in insects: Applications, best practices and biosafety concerns.
    Taning CNT; Van Eynde B; Yu N; Ma S; Smagghe G
    J Insect Physiol; 2017 Apr; 98():245-257. PubMed ID: 28108316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos.
    Gumer JM
    New Bioeth; 2019 Jun; 25(2):137-152. PubMed ID: 31130112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ethics of Gene Editing from an Islamic Perspective: A Focus on the Recent Gene Editing of the Chinese Twins.
    Al-Balas QAE; Dajani R; Al-Delaimy WK
    Sci Eng Ethics; 2020 Jun; 26(3):1851-1860. PubMed ID: 32125604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 30. Various Aspects of a Gene Editing System-CRISPR-Cas9.
    Janik E; Niemcewicz M; Ceremuga M; Krzowski L; Saluk-Bijak J; Bijak M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy.
    Xiao Q; Guo D; Chen S
    Front Cell Infect Microbiol; 2019; 9():69. PubMed ID: 30968001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Starting the conversation: CRISPR's role in India.
    Udwadia F; Singh S
    Indian J Med Ethics; 2019; 4 (NS)(4):300-303. PubMed ID: 31213419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Cas in Medicinal Chemistry: Applications and Regulatory Concerns.
    Duardo-Sanchez A
    Curr Top Med Chem; 2017; 17(30):3308-3315. PubMed ID: 29231142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Designing Ethical Trials of Germline Gene Editing.
    Cwik B
    N Engl J Med; 2017 Nov; 377(20):1911-1913. PubMed ID: 29141166
    [No Abstract]   [Full Text] [Related]  

  • 37. Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome.
    Ebrahimi S; Teimoori A; Khanbabaei H; Tabasi M
    Rev Med Virol; 2019 Jan; 29(1):e2009. PubMed ID: 30260068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene editing: The power and risks of creation.
    Seibert D
    J Am Assoc Nurse Pract; 2019 Feb; 31(2):85-88. PubMed ID: 30747803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
    Li GL; Yang SX; Wu ZF; Zhang XW
    Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects of CRISPR/Cas9 for HIV Elimination.
    Seclen E
    AIDS Rev; 2019; 21(2):109-111. PubMed ID: 31332399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.